In particular, these paints are one of the main causes of concern

In particular, these paints are one of the main causes of concern and require careful assessment, in order to avoid deleterious effects on the natural environment. Biocide-based antifouling paints are a significant localized source of trace elements (in particular copper

and zinc) and organic biocide in the water. In industrial ports the effects of antifouling paints on the biological component can be hardly distinguished from other sources of biocides, such as those generated by industrial activities, commercial shipping and agriculture. Therefore, taking advantage of marinas’ peculiarities in order to assess the effects of the Depsipeptide clinical trial different antifouling paints on marine organisms is an intriguing task. The need to use antifouling coatings is due to the occurrence of fouling organisms, such as algae, barnacles, and tube worms, which recruit and grow on any submerged surface, greatly increasing drag Erastin price and reducing speed and fuel economy of boats. In the last decades, many biocides, such as tributyltin (TBT) copper- and zinc-based compounds, were introduced in order to restrict the recruitment

and growth of fouling organisms on ship and boat hulls. TBT has been referred to as perhaps the most effective antifouling biocide. Nevertheless, due to its negative effects on non-target organisms, it was banned from 2001 onwards, according to the decisions taken by the International Convention on the Control of Harmful Antifouling Systems on Ships, adopted by the International Maritime Organization (IMO). Subsequently, the removal of over-coating of TBT antifouling paints became mandatory from 2008 (IMO, 2001). However, due to the high level of effectiveness of TBT paints, the risk of illegal use Casein kinase 1 is present, even though it should be of minor concern in marinas with respect to commercial

and industrial ports. Copper in the form of cuprous oxide continues to be a mainstay antifouling biocide but not necessarily the most effective. It remains the most commonly used biocide in antifouling paints for recreational vessels. Schiff et al. (2004) demonstrated that these paints, which may have 20–76% of copper content (such as cuprous oxide), leach approximately 4.0 g per cm2 per day or roughly 25 g per month for a typical 9 m power boat. This is a non-negligible quantity that can heavily affect biological communities. Recent studies dealing with the chemical monitoring of sediments showed the occurrence of high concentrations of dissolved copper. Species react to this chemical on the basis of their degree of adaptability giving rise to populations capable to live in waters with high concentration of cupric ions, by modulating the responses of detoxification systems at transcriptional and translational levels.

Oxidative stress responses were also seen in a neuronal cell line

Oxidative stress responses were also seen in a neuronal cell line after in vitro exposure Selleck PD173074 to LUDOX® AS-20 and AM at ≥100 ppm, but not after treatment with the positively charged LUDOX® CL up to the highest tested concentration of 500 ppm ( Kim et al., 2010). Only with the smallest particles (30 nm) the redox potential of cells (GSH) was reduced significantly at concentrations of 50 ppm or higher. Particles larger than 30 nm showed no changes in GSH levels, nor was there ROS formation ( Yu et al., 2009). Ye et al. (2010a) reported that colloidal silica particles (primary particle sizes of 21 and

48 nm, 100–1600 ppm) caused oxidative stress, induced G1 phase arrest and upregulated

levels of p53 and p21 in H9c2(2-1) cells. An increase in IL-8, a key factor in neutrophil chemotaxis was found in vitro in primary human lung fibroblasts ( O’Reilly et al., 2005) and in endothelial cells by Peters and co-workers ( Peters et al., 2004). O’Reilly et al. (2005) found that crystalline and amorphous silica differentially regulated the cyclooxygenase-prostaglandin pathway. In primary human pulmonary fibroblasts, amorphous silica had the ability to directly upregulate the early inflammatory mediator COX-2, the prostaglandin E (PGE) synthase and the downstream antifibrotic mediator PGE2. Precipitated SAS MEK inhibitor clinical trial has been shown to increase the production of macrophage inflammatory protein (MIP)-2 cytokines in primary rat alveolar macrophages (Sayes et al., 2007). Also in the immortalised alveolar type II tumour cell line MLE15, a dose-dependent increased expression Diflunisal of MIP-2 was found after 24 h of incubation with SAS (Aerosil 200) (Singal, 2010 and Singal and Finkelstein, 2005). The increase in MIP-2 protein was partly caused by an increase in ROS generation as it was shown that MIP-2 production was inhibited

by the addition of antioxidants. The silica particles also induced inflammatory gene expression through the activation of nuclear factor-kappa B (NF-κB) and activator protein 1 (AP-1) via the mitogen-activated protein (MAP) kinase pathway. In addition, NF-E2-related factor (Nrf)-2 and HO-1 protein expression were influenced by incubation of MLE15 cells with Aerosil 200. The inflammatory protein expression was delayed as compared to the time course observed with a soluble pro-inflammatory stimulus. The induction of HO-1 via NF-κ B and Nrf2, as well as the extracellular signal-related kinase (ERK) MAP kinase signal transduction pathway were also observed by Eom and Choi (2009) in a human bronchial epithelial cell line exposed to pyrogenic and porous silica particles. Cells exposed to porous silica particles showed a more sensitive response than those exposed to pyrogenic silica.

This may rely on an understanding of what is good, hence includin

This may rely on an understanding of what is good, hence including societal views as well as ecological views (see Mee et al., 2008). Furthermore, Odum (1985) described stress in the system as a set of EIGHTEEN adverse characteristics and so a healthy system by definition should be the converse of those characteristics (see Elliott and Quintino, 2007). The management of an ecosystem and an understanding of the way in which it changes under human influences requires a large amount of data, information and knowledge about the structure and functioning of the system; this can

be described as NINE stages which then allows management decisions to be made (Box 4; McLusky and Elliott, 2004). Such a framework, which is sufficiently generic to cover all human

activities, will encourage managers to obtain selleck chemicals llc the appropriate information for management. By accumulating information in progressing from Stage 1 to Stage 9, conservation and environmental protection bodies can then determine the effects of human activities on the marine system. Each of the ‘decisions’ relates to the way in which the ecosystem functions and Icotinib mouse the behaviour of materials or activities placed in the environment. For example, the placing of dredged material into the sea after dredging will have an effect which depends on the nature of the receiving environment (i.e. whether Amisulpride it has water currents above a threshold speed), and on the nature of the material being dumped (e.g. whether it is sand or mud). However, The Ecosystem Approach is necessary to ensure that all aspects are taken into account and thus that the overall health of systems and the ecosystem services that they deliver are recognised and protected. To detect change then requires monitoring the system – when to assess and what to assess – although we have further complicated this to result in TEN types of monitoring: • Surveillance monitoring – a ‘look-see’ approach which begins without deciding what are the end-points followed by a post hoc detection (a posteriori) of trends and suggested management action. As emphasised here, the aim of

marine management is to protect the whole system although, again as shown here, this is complex achievement. Given this complexity, we often deconstruct the ecosystem into a set of component parts, assess each of them in relation to any stressors and then aim to recombine our assessments to give the management of the whole system – this is what we previously called a ‘deconstructing structural approach’ as used for the European Water Framework Directive (Borja et al., 2010b). The WFD, adopted in 2000, concentrated on assessing deviation from Good Ecological Status by FIVE Biological Quality Elements (phytoplankton, macroalgae, macrophytes, benthic fauna and fishes) plus the chemical and physical characteristics.

19 Our patient is also the first case reported with tracheal invo

19 Our patient is also the first case reported with tracheal involvement in the form of localized intralumnial

multiple nodules All cases with pulmonary EH reported thus far had normal flexible bronchoscopy and no report of intraluminal airway involvement. Even in the 11-year-old male patient reported by Madhusudhan et al. with lung mass encasing the right intermediate bronchus, bronchoscopy did not show any abnormalities.9 Leleu et al. in one of three cases reported with pulmonary EH found that tracheal biopsy in one case was contributory to the diagnosis but didn’t mention whether they biopsied normally or abnormally appearing tracheal mucosa.7 In our case find more we found multiple small nodular lesions in localized area of the trachea where tissue biopsy was obtained and were confirmed to be EH lesions. It is rare to have extreme weight loss with EH as in our case without significant severe liver involvement. Our patient had normal liver function and denied any abdominal complains. In most of cases reported, there is great degree of discrepancy between symptoms and the extent of organ involvement; and lesions could remain asymptomatic for several years. We conclude that patients with

EH can present with multinodular lesions involving more than one organ. This mandates a careful and thorough search for nodules in all visceral organs, bone and soft tissues. Symptoms are nonspecific and depend on the organ most aggressively involved. None of the authors has any conflict of interest. “
“A 94-year-old man sought medical care for left sided chest PI3K inhibitor pain and difficulty in breathing that began 1 day before admission. He had been healthy until 4 days before admission, when sore throat, rhinorrhea, mild cough, and muscle pain. He had medical history of ischemic cardiopathy. On physical examination, he appeared ill with respiratory distress. The respiratory rate was 60 per minute, the heart rate was 120 beats per minute, the temperature was 38.2 °C, and the blood oxygen saturation was 88% in room air. The blood pressure

was 94/68 mm. The Prostatic acid phosphatase heart sounds were normal. The abdomen was soft without hepatosplenomegaly. His neck was supple without signs of meningeal irritation. On chest auscultation, coarse sounds with crackles over both bases were heard. Chest radiograph showed diffuse homogeneous infiltration in the upper lung zones and a confluent area in the right middle lobe without pleural effusion. (Fig. 1). His white blood cell (WBC) count on admission was 4300 cells/mm3 (neutrophils 90%, lymphocytes 6%) and C-reactive protein was 181 mg/dL (reference: <5 mg/dL). The hemoglobin was 14.6 g/dL, and the platelets were 165 x 103/mm3. The venous pH was 7.38, the PCO2 was 38.1 mm/Hg, and the base excess was −2.2. The lactate concentration was 2.30 mmol/L. The serum creatinine was 1.20 mg/dL, and the serum urea nitrogen was 43 mg/dL. The total protein was 6.9 g/dL.

DOPE is one phosphatidylethanolamine, with small polar head when

DOPE is one phosphatidylethanolamine, with small polar head when compared to the hydrophobic tail. This configuration leads to a molecular structure in the form of a truncate cone and its dispersion in water promotes the aggregation in the inverted hexagonal phase (HII) [27]. DOTAP is one of the most popular lipids available for transfection purposes. Its polar head has a propyl ammonium group, which promotes the cationic characteristic (monocationic). The results from EPC/DOTAP indicate the miscibility of

DOTAP in EPC monolayers, as noted in the isotherms and collapse pressure profiles (Fig. 1A and Table 1). The slight non-ideal mixture behavior was confirmed by the mean area per molecule curves (Fig. 1B), indicating the presence of attractive this website forces at higher surface pressures. The intuitive idea of mixing DOTAP in EPC is that the electrostatic repulsion among the cationic polar head groups induces a lateral expansion of the lipid monolayer and the higher the DOTAP content, the more intense this effect

is, which explains the maximum compression modulus Cs−1 profiles in Fig. 1D and Table 1. We could observe that for XDOTAP in the range of 0.4–0.6 the Cs−1 values are selleck inhibitor similar ( Table 1). An interesting behavior occurs for the analysis of excess free energy (ΔGExc) ( Fig. 1C). When XDOTAP is in the same range (0.4–0.6), the ΔGExc reaches a minimum. This behavior indicates that at this mixed monolayer concentration there is an optimum balance between the induced dipoles from the zwitterionic and cationic charges

from the polar headgroups. Additionally, we can observe that when XDOTAP is increased the ξ value increases from −0.79 (XDOTAP = 0.2) to 0.89 (XDOTAP = 0.8), suggesting that there is a kind of transition (at XDOTAP = 0.6–0.4) from the viewpoint of interaction energy. Similar studies of monolayers composed of a zwitterionic phosphatidylcholine and a cationic lipid were evaluated by Zantl et al. [13]. DMPC/DMTAP (dimyristoylphosphatidyl-choline/dimyristoyl-trimethyl-ammonium selleck compound propane) monolayers presented a minimum in the area per headgroup at mol fraction of about 0.5, using simultaneous small and wide-angle X-ray scattering [13]. In a similar study, Matti et al. [28] characterized mixed monolayers composed of cationic gemini surfactant, 2,3-dimethoxy-1,4-bis(N-hexadecyl-N,N-dimethyl-ammonium)butane dibromide (abbreviated as SS-1, a divalent cationic lipid) and its mixtures with 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) using Langmuir monolayer studies. The authors identified that the minimum area per lipid was reached when XSS-1 = 0.38. Similar results were also obtained by molecular simulation [11] and [12]. In all of the above cases, the authors investigated synthetic lipids. Zantl et al. [13] studied mixed monolayers formed by lipids with the same hydrophobic tails and the studied effects are exclusively a consequence of hydrophilic headgroups interactions. Matti et al.

In addition, Korean red ginseng improves arterial stiffness in hy

In addition, Korean red ginseng improves arterial stiffness in hypertension [50]. Overall, these results show the improvement in vasomotor function by ginseng. It has initially been thought that ginseng may increase blood pressure to harmful levels. However, previous studies have shown that ginseng

cures patients with low blood pressure, restoring it to normal levels. In addition, ginseng also reduces blood pressure in patients with high blood pressure [51]. The blood pressure lowering activity of Korean ginseng is attributed to the production of vascular endothelial cell-derived NO [52]. Recent studies have shown that ginseng this website has biochemical and pharmacological activities beneficial for blood pressure control, where lower doses have greater antihypertensive effects than higher doses [53], and improve blood circulation through vasodilation [52]. The antihypertensive effect of ginseng is mediated by the inhibition of myogenic responses on the blood vessels [54]. In addition, ginseng protects against tissue damage and is also a novel therapy Selleckchem GW 572016 for heart failure [55]. Saponins from P. notoginseng protected the heart against doxorubicin-induced cardiotoxicity [56] and blocked the cardiac hypertrophy induced by monocrotaline in rats [57]. Left ventricular hypertrophy produced by aortic coarctation was protected by ginsenoside Rg1 through NO

functions [58]. Electromechanical alternans was suppressed by ginsenoside Re in cardiomyocytes [59], and myocardial infarction after ischemia and reperfusion was preconditionally protected by ginsenoside Rb1 [60]. Another study showed that ginsenoside Rg1 inhibits left ventricular hypertrophy [61]. P. ginseng also suppresses apoptosis in neonatal cardiocytes by modulating cAMP Bcl-2 and caspase-3 activities during hypoxia and reperfusion [62]. Furthermore, cardiomyocytes have been protected by ginsenoside Rg1 from oxidative injury through antioxidation

and intracellular calcium modulation [63]. Total saponin, panaxadiol, and panaxatriol from ginseng have been able to protect cardiomyocytes from ischemia and reperfusion injuries [64]. Cardiac injury in diabetes induced by streptozotocin has been prevented by ginsenoside Rb1 [65] and unfavorable postmyocardial remodeling was reduced by ginseng [66]. Some studies suggest that cardiac hypertrophy and heart failure are prevented by ginseng through Nhe-1 modulation and reduction of calcineurin activation [67]. Recent studies also show that cardiac protection by NO was facilitated by compound K through the Akt/PI3K pathway [68]. Acute cardiac injury from ischemia and reperfusion has been protected through the GR and estrogen receptor-activated risk pathway by the eNOS-dependent mechanism in rats [69]. Thus, these studies suggest that ginseng preserves heart function after myocardial tissue deterioration.

In this study we used two regional non-host controls and found th

In this study we used two regional non-host controls and found that, for the common period, the reconstructed outbreaks had high fidelity in terms of timing, duration and frequency (Fig. 2). Sources of inconsistency between the two reconstructions were associated with the start and end years of outbreaks, a broad problem with the outbreak detection method employed here due to lag effects between budworm defoliation and subsequent growth suppression (Thomson and van Sickle, 1980, Alfaro et al., 1982 and Swetnam and Lynch, 1989) and in the intensity of individual outbreaks.

For example, outbreak reconstructions using the regional lodgepole pine non-host show a higher intensity outbreak in the 1800s than the ponderosa pine non-host, while the reverse was true for the 1900s outbreak (Fig. 2b). We attribute buy LY294002 these differences to the degree and type of climatic variability captured by each non-host (limitation 2 identified above), as well as the potential for local endogenous processes to be reflected in the year-to-year variation in the tree-ring series.

Using the longer regional ponderosa pine non-host chronology (Table 1), we identified 12 low-intensity WSB outbreaks over a 435-year period, or one outbreak approximately every 36 years. This finding is similar to those of Campbell et al. (2006) who identified 8 WSB outbreaks over a 300-year period or selleck compound one 3-oxoacyl-(acyl-carrier-protein) reductase outbreak approximately every 37 years in the southern interior of BC. While we identified low-intensity events when ⩾15% of trees recorded

an outbreak, Campbell et al. (2006) identified an outbreak when ⩾35% of trees recorded an outbreak (Table 5). The application of a minimum threshold can be effective at differentiating between low and moderate intensity outbreaks. However, the threshold itself is somewhat subjective, as it is not based on theoretical or experimental values. It is possible that the threshold minimum of 35% may be too conservative and exclude small and/or low intensity events (Ann M. Lynch, personal communication). Defoliation impacts are often highest among trees in the suppressed and intermediate height classes ( Alfaro and Maclauchlan, 1992), yet in our study (and others) canopy dominants were selected for reconstruction purposes to obtain the longest possible records. These individuals, however, may not be capturing the full impact of budworm feeding. When we increased the minimum threshold to 50% (moderate) the number of reconstructed outbreaks dropped to 5 (from 12) that on average lasted 11 years with a return interval of 64 years ( Table 5). While the duration of low and moderate intensity events were similar (15 versus 11 years), the return interval increased two-fold ( Table 5), which is consistent with return intervals reconstructed for WSB outbreaks in the Colorado Front Range ( Ryerson et al., 2003).

Jonathan specifically notes that he believes these thoughts to be

Jonathan specifically notes that he believes these thoughts to be true and that they are a major barrier to his ART adherence. In this segment, Jonathan and his therapist discuss

selleck chemical cue-control strategies for improving medication adherence. The therapist draws upon the patient’s previously listed barriers to medication adherence (i.e., self-blaming thoughts get in the way) and motivations to stay healthy (i.e., watching daughter grow up) in walking through the steps of AIM in order to personalize the skill and demonstrate its effectiveness. The patient and therapist first “articulate” the specific adherence goal, which is to have more balanced thoughts about medication adherence (e.g., “medications help me stay healthy for my daughter”). Next, they “identify” barriers to this goal, including self-blaming thoughts (e.g., “I deserve to be sick”). Finally, they “make a plan” and back-up plan to address these barriers. This video clip illustrates the cue-control strategies life-step, and these two strategies are used for click here a plan and back-up plan. The first cue-control strategy involves

writing down motivations for staying healthy and more balanced thoughts about medication adherence on notecards that can be referenced by the patient when he has negative thoughts. The second strategy involves using colored stickers to trigger the patient to think of his motivations for staying healthy. These stickers can be placed in various locations that will be seen by the patient during his medication target time (e.g., on the TV) and throughout the day (e.g., on cell phone case). Although the notecards and stickers can be placed anywhere in the home, the stickers provide a more discrete cue-control strategy for patients who are concerned about disclosing their HIV status to others in the home. The primary goal of Session 2 is to provide an overview

of CBT-AD and to deliver psychoeducation with regard to the co-occurrence of depression, HIV infection, and ART nonadherence. As is the case with traditional CBT for depression (Beck, 1987), the core component PFKL of this session is to present a three-part model of depression (i.e., the interaction between cognitions/thoughts, behaviors/actions, and physiological reactions), tailored to the unique experiences of the patient. A detailed overview of this procedure can be found elsewhere (Safren et al., 2008b). Specific to CBT-AD, presentation of a three-part model of depression focuses on eliciting thoughts, behaviors, and physiological reactions that are specific to experiences with HIV infection, as well as ART adherence. By describing these specific aspects of HIV-infection and ART adherence when reviewing the three-part model, the patient is able to draw connections between their depressive symptoms and management of their health. Session 2 ends with a motivational exercise, based on strategies outlined by Miller and Rollnick (1991).

In conclusion, no long-term safety problems were observed in a li

In conclusion, no long-term safety problems were observed in a limited number of miravirsen-treated patients and targeting of miR-122 may be an effective treatment strategy for HCV infected patients. This study was initiated by the Academical Medical Center, Amsterdam in the Netherlands. Other participating hospitals were Erasmus Medical Center in the Netherlands, J.W. Goethe University Hospital in Germany, University of Texas Health Science Centre in the USA, Fundacion de Investigacion in Porto Rico, University Hospital Bratislava in Slovakia and Medical University of Warsaw in Poland in collaboration

with PRA International and Santaris Pharma. “
“This article provides an overview of the invited lectures at the 27th International Conference on Antiviral Research, sponsored Galunisertib by the International Society for Antiviral Research (ISAR), which was held in Raleigh, North Carolina, USA from May 12 to 16, 2014. It begins with reports of lectures by the recipients of ISAR’s three major awards, held in memory of Gertrude Elion, Antonín Holý and William Prusoff. These are

followed by brief summaries of the keynote addresses and the three mini-symposia on “Hepatitis B virus”, “Research Triangle Park” and “Challenges GDC-0199 datasheet in HIV infection, treatment and prevention”. Because this review article simply provides short accounts of oral presentations, it is not generally accompanied by references to the scientific literature. Any descriptions of favorable treatment outcomes should not be taken as recommendations for clinical use. John C. Drach, Ph.D., University of Michigan, Ann Arbor, Michigan, USA (Fig. 1). Gertrude B. (Trudy) Elion was born in New York City and was pleased to work for the Burroughs Wellcome Co. when based in New York but was concerned when it transferred to Research Triangle Park, North Carolina,

not many miles from this year’s meeting site. However, within just a few months she declared that she was “at home” in North Carolina. She was awarded the Nobel Prize in Physiology or Medicine in 1988 for her pioneering work in purine biosynthesis which paved the way for the discovery of drugs to treat organ rejection, cancer and viral diseases. The focus of PAK5 John’s presentation was on the research conducted in his own and his collaborators’ laboratories that ultimately led to the invention of three compounds which were discovered to have antiviral activity against human cytomegalovirus (HCMV) and which later entered clinical trials: BDCRB pyranoside (GW275175X) (Phase I), maribavir (Phases I, II and III) and cyclopropavir (Phase I). His major collaborators included Karen Biron, Charles Shipman, Leroy Townsend, and Jiri Zemlicka. To date, there are only five FDA-approved drugs for treatment of HCMV infections: cidofovir, fomivirsen, foscarnet, ganciclovir and valganciclovir.

3A and 4A and B, respectively Two classes of genes, the early (E

3A and 4A and B, respectively. Two classes of genes, the early (E) genes (which

are required for viral DNA replication) and late (L) genes (coding for the structural proteins) exist in both PyVs and PVs. The HPV genome contains a coding region that encompasses an E region that includes up to seven ORFs encoding non-structural proteins and the late region comprises the L1 and L2 ORFs. In HPV, a ∼1 kbp non-coding region [also known as the long control region (LCR) or the upstream regulatory selleck region] separates the early and late regions. The LCR harbours the origin of replication, the transcription start sites and promoter/enhancer elements that regulate viral gene expression. In PyV, both strands of DNA code for the viral proteins. One strand of DNA encodes an overlapping set of multifunctional early regulatory proteins and the other strand encode for the capsid proteins expressed late in permissive cells. Some PyVs also encode for an agno protein that facilitates virion assembly. The control region between the early and the late transcription units contains a bidirectional enhancer, early and late promoters, the viral origin of replication, the viral packaging Epacadostat in vivo signal and binding sites for host transcription factors Table 3. Papillomavirus particles are ∼55 nm diameter, compared to ∼45 nm diameter in PyVs. Papillomaviruses encode two structural proteins: the major capsid protein, L1 (∼510 amino acids

and ∼58 kDa), and the minor protein L2 (∼470 amino acids and ∼51 kDa). In contrast, PyVs encode for three structural proteins: the major capsid protein, VP1 (∼370 amino acids and ∼41 kDa) and two minor proteins VP2 selleck compound (∼350 amino acids and ∼38 kDa) and VP3 (∼230 amino acids and ∼26 kDa). Despite significant differences in amino acid sequences of the major capsid

proteins, both PV and PyV capsids exhibit conserved features, as the 72 capsomers are pentamers of the major capsid protein and are arranged on a T = 7 icosahedral lattice. Papillomaviridae and Polyomaviridae differ in capsomer morphology and size. Papillomavirus capsomers are star-shaped, 11–12 nm in diameter, while polyomavirus are barrel-shaped, 8 nm in diameter. Intercapsomer interactions are also slightly different between these viral families (Belnap et al., 1996). The carboxyl terminus of VP1 or L1 mediates contacts between the pentamers in the capsid. While disulphite bonds stabilize the interpentamer contacts for L1, both disulphite bonds and calcium bridges stabilize these contacts for VP1 (Sapp and Day, 2009). Also, differences in receptor binding and internalization pathway also exist between PVs and PyVs, reviewed in (Sapp and Day, 2009). Polyomaviruses generally have a narrow host range and limited cell type tropism (Gjoerup and Chang, 2010). In their natural host, they are able to infect cells giving rise to a productive life cycle causing cell lysis.